MedTrace Logo

Registry Platform Gastric/Esophageal Cancer (SAPHIR)

NCT04290806 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1900

Last updated 2026-01-28

No results posted yet for this study

Summary

The registry aims to collect and analyse information on the antineoplastic treatment of patients with metastatic esophageal, gastric or gastroesophageal junction cancer, treated in palliative intention in daily routine practice in Germany.

Conditions

Interventions

OTHER

Routine care as per site standard

Physician's choice according to patient's needs. Routine care as per site standard.

Sponsors & Collaborators

  • iOMEDICO AG

    lead INDUSTRY

Principal Investigators

  • Tobias Dechow, Prof. · Ravensburg

  • Florian Lordick, Prof. · Leipzig

  • Sylvie Lorenzen, Prof. · München

  • Karin Potthoff, Dr. · Freiburg

  • Anke Reinacher-Schick, Prof. · Bochum

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-04
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • Germany

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04290806 on ClinicalTrials.gov